Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment

By: via Benzinga
Halozyme Therapeutics, Inc. (NASDAQ: HALO) and Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.